Beng Yang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 6
- Cancer-related gene regulation 5
- Circular RNAs in diseases 3
-
- MicroRNA in disease regulation 6
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Jian Wu (13 shared papers)Shusen Zheng (14 shared papers)Junru Chen (6 shared papers)Rongliang Tong (13 shared papers)Yunhao Chen (6 shared papers)Haiyang Xie (10 shared papers)Lin Zhou (6 shared papers)Yanpeng Zhang (4 shared papers)
- Journals
- Molecular Cancer (2 papers)Advanced Science (2 papers)International Journal of Oncology (2 papers)Cancer Letters (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaMadagascarUnited States
In The Last Decade
Beng Yang
27 papers receiving 1.9k citations
Beng Yang's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 752
- Molecular Biology 1.2k
- Inorganic Chemistry 192
- Biomaterials 90
- Oncology 162
Countries citing papers authored by Beng Yang
This map shows the geographic impact of Beng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beng Yang more than expected).
Fields of papers citing papers by Beng Yang
This network shows the impact of papers produced by Beng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beng Yang. The network helps show where Beng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Beng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1 Hit paper breakdown → | 2019 | 489 |
| 2 | 2017 | 314 | |
| 3 | 2020 | 208 | |
| 4 | 2019 | 151 | |
| 5 | 2020 | 150 | |
| 6 | 2023 | 96 | |
| 7 | 2020 | 73 | |
| 8 | 2021 | 61 | |
| 9 | 2019 | 54 | |
| 10 | 2018 | 44 | |
| 11 | 2019 | 41 | |
| 12 | 2019 | 28 | |
| 13 | 2023 | 27 | |
| 14 | 2023 | 24 | |
| 15 | 2016 | 24 | |
| 16 | 2018 | 22 | |
| 17 | 2023 | 20 | |
| 18 | 2024 | 19 | |
| 19 | 2017 | 17 | |
| 20 | Dimethyl fumarate suppresses hepatocellular carcinoma progression via activating SOCS3/JAK1/STAT3 signaling pathway. | 2019 | 16 |
About Beng Yang
Beng Yang is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 1.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers), Cancer-related gene regulation (5 papers), Ferroptosis and cancer prognosis (3 papers), Circular RNAs in diseases (3 papers), Cancer, Lipids, and Metabolism (2 papers), interferon and immune responses (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Cancer Research (752 citations), Molecular Biology (1.2k citations), Inorganic Chemistry (192 citations), Biomaterials (90 citations) and Oncology (162 citations). Beng Yang has collaborated with scholars based in China, Madagascar and United States. Frequent co-authors include Jian Wu, Shusen Zheng, Junru Chen, Rongliang Tong, Yunhao Chen, Haiyang Xie, Lin Zhou, Yanpeng Zhang, Chuanhui Peng and Bin He. Their work appears in journals such as Molecular Cancer, Advanced Science, International Journal of Oncology, Cancer Letters and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.